MedTrace Logo

Assessment of the Safety and Effectiveness of a Micro-RF Skin Treatment Device (nebulyft）

NCT06623214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-10-03

No results posted yet for this study

Summary

The objective of the study is to evaluate the safety, efficacy and usage compliance of the home-use device nebulyft for self-treatment of wrinkles appearance. The participants do treatment 5 time /week and last 4 weeks. Each treatment takes 16min to complete. Photographs will be taken before treatment and 1 month after the completion of treatment to compare the wrinkle scale.

Conditions

  • Wrinkle Reduction

Interventions

DEVICE

nebulyft

Micro Radiofrequency Skin Treatment Device(nebulyft)

Sponsors & Collaborators

  • Hangzhou Rebecca Medical Science and Technology Ltd.

    lead INDUSTRY

Principal Investigators

  • Tony Shum, MD · DSC Laser & Skin Care Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-07
Primary Completion
2024-08-13
Completion
2024-08-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06623214 on ClinicalTrials.gov